Orphan Drug Conference USA 2017
May 22, 2017
Orphan Drugs Conquering Rare Diseases One-by-One.
The Orphan Drug Conference USA 2017 welcomed thousands of attendees as science, industry, big pharma, and patient advocacy groups met in Washington, D.C. Their objective? To develop therapies, raise research money and bring the challenge of defeating rare diseases to the forefront. Sponsored by global events company Terrapinn, the event is in its seventh year.
Primary HLH is a rare, rapidly progressive, and fatal disorder with a median survival of less than 2 months.
ScoreSense's platform is an easy-to-navigate website that gives you access to update your credit scores and reports monthly.
As we immerse ourselves back into life post-COVID-19, we want to make sure we’re doing it safely and efficiently. Knowing our level of protection against the virus could help us do that.